Eledon Pharmaceuticals (ELDN) vs Yarrow Bioscience (YARW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Yarrow Bioscience (YARW) has outperformed Eledon Pharmaceuticals (ELDN) over the past year, losing 7.6% versus a loss of 15.7%. Over five years, ELDN leads with a -57.0% price change compared with -98.2% for YARW. Eledon Pharmaceuticals is the larger company by market cap ($196.7 million vs $184.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELDN | YARW |
|---|---|---|
| Share price | $2.42 | $19.87 |
| Market cap | $196.65M | $184.88M |
| 1-day change | 0.00% | +5.83% |
| YTD return | +60.26% | -31.48% |
| 1-year return | -15.68% | -7.58% |
| 5-year return | -57.02% | -98.19% |
| EPS (TTM) | $-0.90 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.60 | $46.95 |
| 52-week low | $1.35 | $16.05 |
| Distance from 52-week high | -47.39% | -57.68% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +271.90% | +186.86% |
| Average volume | 935.08K | 88.98K |
| Shares outstanding | 81.26M | 9.30M |
| Employees | 33 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Yarrow Bioscience
YARW stock →Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
ELDN vs YARW FAQ
Which is bigger, Eledon Pharmaceuticals or Yarrow Bioscience?
Eledon Pharmaceuticals (ELDN) is larger, with a market capitalization of $196.65M compared with $184.88M for Yarrow Bioscience (YARW).
Which stock has performed better over the past year, ELDN or YARW?
YARW returned -7.58% over the past 12 months, compared with -15.68% for ELDN (price return, excluding dividends). Past performance does not predict future results.
Are Eledon Pharmaceuticals and Yarrow Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.